Tobacco deprivation has been found to produce many symptoms in chronic smokers. While increased craving for tobacco is most commonly reported, a wide variety of other symptoms have also been reported, including changes in physiological, psychomotor and subjective functioning (see Jaffe and Jarvik 1978; USDHEW 1979; Shiffman 1979) . This observation has led to the belief that a tobacco withdrawal syndrome exists which implies a physical dependence to tobacco. However, at the present time, it is unclear if all or any of the reactions following tobacco deprivation are in fact indicators of physical dependence. This uncertainty exists in part because of the lack of systematic and comprehensive studies of tobacco withdrawal similar to the classical studies such as those which have examined opiate withdrawal symptoms (Himmelsbach 1942) . The classical studies of withdrawal phenomena have tended to examine a variety of signs and symptoms in a prospective fashion with measurements obtained on repeated occasions both during baseline and drug deprivation.
In contrast, most previous investigations on tobacco withdrawal symptoms have been either retrospective, employed only a limited number of measures, employed no baseline period or failed to include control groups. Furthermore, in order to define reactions to tobacco deprivation as a true withdrawal syndrome, it is necessary to rule out the possibility that these symptoms are attributable to removal of drug action, to a loss of a reinforcer, or a disruption of a habit.
A careful examination of tobacco withdrawal is important not only to better understand factors which maintain smoking, but also to develop more effective smoking treatment procedures.
For example, if specific signs and symptoms after tobacco deprivation are due to pharmacological withdrawal, then pharmacological intervention to treat these symptoms may provide the best treatment outcome.
Over the past few years we have been conducting studies to determine reliable and valid indicators of tobacco withdrawal. We have also attempted to determine if nicotine replacement can reduce the number or intensity of tobacco withdrawal symptoms.
Two studies have been completed describing the characteristics of tobacco withdrawal, and one study has been completed determining if withdrawal symptoms can be alleviated with nicotine replacement. This paper will describe the results of these studies, as well as investigations currently underway.
TOBACCO WITHDRAWAL SYMPTOMS IN A CONTROLLED ENVIRONMENT
In the first study ), a prospective examination of tobacco withdrawal symptoms was undertaken while subjects (chronic smokers) lived in a controlled environment. Subjects were hospitalized in the General Clinical Research Center of the University of Minnesota Hospitals. This Center is a federally funded unit established to support clinical research, and contains its own staff of physicians, nurses, and dieticians as well as its own biochemical laboratory and kitchen facilities. In the study, subjects (N=27) were hospitalized for seven consecutive days. For the first 3 days, they were allowed to smoke ad lib while a battery of tests (see table 1) was administered 1-2 times a day. For the next 4 days, subjects in the experimental group (N=20) were required to abstain from all tobacco use, while subjects in the control group (N=7) were allowed to continue to smoke ad lib. Compliance was monitored by random carbon monoxide breath samples and observations by the nursing staff.
The study has yielded several interesting findings. First, few of the measures changed significantly after tobacco deprivation. Of the 37 measures examined, significant effects were found with only 9. Physical measures that changed significantly were a decrease in heart rate, and increases in caloric intake and body weight. Subjective measures increasing significantly were craving for tobacco, confusion and depression-dejection scores on the POMS, and reports of number of awakenings and duration of awakenings during the sleep period. The only other significant change was reports by observers that the subject had difficulty concentrating (table 2). The remaining 28 measures in table 2 did not change following tobacco deprivation.
As part of the study, the time course of withdrawal measures was examined over the 4 days of tobacco deprivation.
Self-report symptoms such as craving for tobacco, confusion, number of awakenings and duration of the awakenings, and depression-dejection peaked within 24 to 72 hours after tobacco deprivation and then declined. Caloric intake increased over the first 72 hours of tobacco deprivation and decreased after 96 hours, while weight continued to increase.
Similarly heart rate decreased initially with a slight increase after 96 hours of deprivation. This finding would indicate that some of these symptoms may not solely be due to the removal of a pharmacological effect.
There may be several reasons for our failure to find significant changes in measures that other studies have reported following tobacco deprivation. One reason may be our inclusion of a control group.
We found that addition of the control group eliminated findings that would have been significant if only a baseline/deprivation comparison had been made. For example, restlessness increased significantly from baseline to the deprivation period for subjects in the experimental group.
However, there was also an increase in this measure for subjects in the control group over the same period of time.
Thus, the inclusion of a control prevented an erroneous a measure not employed in study + increase -decrease * significant effect of nicotine gum on tobacco withdrawal symptoms conclusion from being drawn, as would have happened if data from only the experimental group had been analyzed.
A second reason we found few tobacco withdrawal symptoms may be related to the type of environment in which the study was conducted.
In a controlled hospital environment, subjects are not exposed to many of the stimuli that are typically associated with their smoking.
If environmental factors play a role in determining the intensity of tobacco withdrawal symptoms (Pomerleau 1981) , then hospitalization may have minimized the intensity of those symptoms.
The third reason for our failure to find withdrawal symptoms that others have reported may be the large between-subject variability in our data.
This would reduce the likelihood of our obtaining a statistically significant effect.
For example, for blood pressure and temperature, some subjects showed an increase, other showed no change, while still others showed a decrease on these measures. Across subjects, such effects tend to cancel out, leaving no net change for the group.
TOBACCO WITHDRAWAL SYMPTOMS IN THE NATURAL ENVIRONMENT
In the first study, lack of environmental stimuli typically associated with smoking was suggested as one reason for relatively few withdrawal symptoms being found. A second study was therefore conducted to examine tobacco withdrawal symptoms as they occur in the natural environment. This study was part of a larger investigation designed to examine the effects of nicotine gum on tobacco withdrawal symptoms . The project was conducted with outpatients who returned to the smoking clinic for measurement of withdrawal symptoms. After two evenings of baseline measurement, subjects were randomly assigned to either nicotine or placebo gum groups in a double-blind manner. Subjects were then asked to stop smoking, chew nicotine gum or placebo gum ad lib, and return to the smoking clinic for measurements on the first, second, and fourth evenings of tobacco deprivation.
For our present purposes, only data from the placebo group (N=49) will be examined.
(The effect of nicotine gum on tobacco withdrawal symptoms will be described in a later part of this paper.) Since the study was double-blind, the effects of subject and experimenter expectancy on tobacco withdrawal symptoms were controlled. The measures employed in this study are shown in table 1.
In this study, the physiological measures that changed significantly following tobacco deprivation were supine and orthostatic heart rate. Both decreased with tobacco deprivation. Measures on the self-rating checklist that changed significantly were craving for tobacco, irritability, anxiety, impatience, difficulty concentrating, and restlessness. All increased with tobacco deprivation. The results obtained with the Profile of Mood States (POMS) were similar to the results obtained with the self-rating checklist, where significant increases in the anger-hostility, anxiety-tension, and confusion scores, and decreases in the vigor score were obtained.
Behavioral observations by others tended to confirm the self-report results, where significant increases in irritability, anxiety, restlessness, and impatience were obtained. Other significant changes reported by subjects included decreased tremulousness, increased hunger, increased eating, increased somatic complaints, and increased number of awakenings during sleep and sleep problems. As in the first study, most of these withdrawal symptoms began shortly after onset of tobacco deprivation and peaked 24-48 hours later.
Compared to the inpatient study, the outpatient study found a greater number of significant changes following tobacco withdrawal (see table 2 ). The symptoms found in common in the two studies were a decrease in heart rate and increases in craving for tobacco, difficulty concentrating, eating behavior, and number of awakenings during sleep. Unlike the previous study, however, the outpatient study results included no statistically significant increase in body weight, duration of awakening during sleep, or depressiondejection score on the POMS. On other common measures, a decrease in tremulousness, an increase in anger-hostility and tensionanxiety scores, and a decrease in vigor score on the POMS were found in the outpatient study but not in the inpatient study.
EFFECTS OF NICOTINE ADMINISTRATION ON TOBACCO WITHDRAWAL SYMPTOMS Do tobacco withdrawal symptoms result from nicotine deprivation?
Other studies attempting to answer this question have focused on whether frequency of smoking cigarettes is related to severity of withdrawal and have obtained equivocal results (Shiffman 1979) . In the present study, however, we attempted to determine whether nicotine gum relieves tobacco withdrawal symptoms. This study is important not only in determining whether physiological dependence on nicotine can occur, but also for clinical reasons. If relapse to smoking is related to the appearance of aversive nicotine withdrawal symptoms following tobacco deprivation, then attenuation of withdrawal symptoms by other forms of nicotine administration could improve smoking cessation success rates (Russell et al. 1980 ). Subjects were 100 smokers who met the criteria for Tobacco Dependence and who had a history of Tobacco Withdrawal as defined by the DSM III criteria (APA 1981) .
Subjects were randomly assigned to either a nicotine (2 mg) gum or placebo gum group.
Following 2 days of smoking baseline, all subjects were required to undergo 4 days of tobacco deprivation, during which time they were instructed to chew the gum (either nicotine or placebo) on a PRN basis. Measures employed are shown in table 1. Only those symptoms that changed signficantly following tobacco deprivation in the placebo group were examined in the analysis.
The nicotine gum group reported significantly less irritability, anxiety, difficulty concentrating, restlessness, impatience, and somatic complaints after smoking cessation than the placebo gum group on the self-rating checklist. Reductions in these withdrawal symptoms were confirmed by subjects' scores on the Profile of Mood States and by observer ratings. Nicotine did not reduce the increase in cigarette craving, hunger, eating, and insomnia, or the decrease in tremulousness and supine heart rate that occurred after smoking cessation. The effect of the nicotine was evident on the first day of deprivation and throughout the 4-day tobacco deprivation period.
In summary, it appears the nicotine relieves some, but not all, of the symptoms of tobacco deprivation. There are a number of factors which may account for the failure of the gum to relieve all tobacco withdrawal symptoms.
For example, the gum dose that was used in the study may have been inadequate.
Second, it may be that nicotine must be given in a bolus form (i.e., as delivered in smoking) to relieve some symptoms of withdrawal (Russell and Feyerabend 1978) .
Third, there may be other psychoactive ingredients in tobacco in addition to nicotine which are correlated with physiological dependence on tobacco (Jarvik 1981) . Fourth, tobacco withdrawal symptoms may be controlled by behavioral or psychological as well as a pharmacological factors (Falk 1971; Jaffe and Jarvik 1978) .
CURRENT INVESTIGATIONS
A study is currently being undertaken to determine the withinsubject reliability of tobacco withdrawal symptoms. The study employs a modified single-subject A-B-A-B experimental design. Following an intial 48-hour period during which baseline measures are obtained while subjects smoke ad lib, subjects are required to undergo a 96-hour period of tobacco deprivation. After the deprivation period, subjects are asked to resume smoking for a 96-hour period (during the latter half of which additional baseline measures are obtained). This second baseline period is followed by a second 96-hour tobacco deprivation period. Preliminary analysis of the data from three subjects showed that decreases in supine heart rate and in vigor score on the POMS, and increases in caloric intake, anger-hostility, and number of awakenings during sleep occurred consistently both within and across subjects during both periods of deprivation.
In five out of six measurement periods, craving and confusion score on the POMS also increased. Measures which showed consistent effects of tobacco deprivation within but not across subjects include orthostatic heart rate change. All other variables showed inconsistent changes between and within subjects over the two tobacco deprivation periods.
SUMMARY
In total, our studies show that changes which occur reliably and consistently in chronic smokers after tobacco deprivation include: (1) decreased heart rate, (2) increased caloric intake/eating, (3) increased number of awakenings during sleep, (4) increased craving for tobacco, and (5) increased confusion, as measured by the POMS. Other changes that were found to occur after tobacco deprivation in some but not all of our studies include decreased orthostatic heart rate, increased irritability, and decreased vigor score on the POMS.
Previous investigators have found a consistent effect of tobacco deprivation on heart rate (Gilbert and Pope 1982; Knapp et al. 1963; Parsons and Hamme 1975; Weybrew and Stark 1967; Glauser et al. 1970; Myrsten et al. 1977; Murphee and Schultz 1968) . Although decreased blood pressure (Knapp et al. 1963; Murphee and Schultz 1968) and changes in other vital signs such as temperature (Gilbert and Pope 1982; Myrsten et al. 1977; Ague 1974 ) have been reported, our present studies and studies by others (Weybrew and Stark 1967; Glauser et al. 1970) failed to find a significant deprivation effect on these measures.
Perhaps the contradictory findings are a function of the reliability of the measures themselves or of the population tested.
Caloric intake has been found to increase in both animals and humans after nicotine or smoking cessation (Gruneberg 1982; Myrsten et al. 1977; Wack and Rodin 1982) . These results are consistent with studies which have found that smoking cessation causes an increase in body weight (Wack and Rodin 1982) . However, previous studies disagree on how smoking cessation causes weight gain. Our inpatient study is believed to be the first to simultaneously measure changes in caloric intake, fluid retention, and physical activity after tobacco deprivation.
In the study, caloric intake increased but fluid retention and physical activity did not change. The increases in weight may not be accounted for solely by increases in caloric intake. There may be other factors such as decreased basal metabolic rate which cause the increase in weight.
Other studies have also reported sleep disturbance or insomnia among tobacco-deprived smokers (Larson et al. 1961; Weybrew and Stark 1967) .
Studies directly monitoring sleep have found a decrease in duration awake (Soldatos et al. 1980) , increased REM sleep (Soldatos et al. 1980; Kales et al. 1970; Parsons et al. 1975) , and increased Stage IV (>50% delta waves) sleep (Parson et al. 1975; Parsons and Hamme 1975) . Thus, objective data indicate that after tobacco deprivation smokers actually sleep longer, which contradicts subjective reports of insomnia.
Difficulty concentrating after tobacco deprivation has also been reported by other investigators (Weybrew and Stark 1967; Frankenhauser et al. 1971; Myrsten et al. 1977; Wynder et al. 1967) . The difficulty may be reflected in poor performance shown by tobaccodeprived smokers on driving simulation (Heimstra et al. 1973 ) and vigilance (Ashton and Stepney 1982) tasks.
Furthermore, smokers deprived of tobacco have shown an increase in slow wave activity (Ulett and Itil 1969) and slower dominant alpha frequency (Knott and Venables 1977) which are associated with a hypoexcitation state and perhaps a decrease in attention (Knott and Venables 1977; Ashton and Stepney 1982) .
Subjective reports of craving for tobacco, increased irritability, and decreased vigor have been widely cited in other studies (Shiffman 1979) . Craving for tobacco has been found to be the most prevalent withdrawal symptom reported by exsmokers, with up to 90 percent of smokers who quit reporting a craving for tobacco (Guil-ford 1966) . While most of these mood changes have been obtained by self-report, two studies have employed objective measures of irritability or anger. Hutchinson and Emley (1973) found that masseter muscle contraction increased in frequency in 7 of 8 subjects withdrawn from tobacco. Schechter and Rand (1974) found higher aggression scores in chronic smokers on the Buss Aggression Machine when subjects were deprived of cigarettes than when allowed to smoke.
The time course for symptoms that were examined after tobacco deprivation would suggest that some of the symptoms are not primarily due to the removal of a pharmacological effect and consequently a return to values prior to the onset of smoking. The onset of most symptoms was rapid (within 24 hours of onset of deprivation), reached a peak in 36 to 72 hours, and then gradually declined. Other investigators have also noted that the peak in tobacco withdrawal symptoms based on subjective reports occurs between 24 and 48 hours (Shiffman and Jarvik 1976) . If these symptoms would have been due to return to baseline, symptoms would not have shown the "overshoot" or "rebound" pattern that has been found in the opiate withdrawal syndrome (Himmelsbach 1942 ).
Our study indicates that nicotine appears to affect the occurrence of some but not all symptoms of tobacco withdrawal. Previous studies have also found that administration of nicotine minimizes tobacco withdrawal symptoms (Hughes and Hatsukami, this volume) . The only symptom that has been consistently found to be reduced by the administration of nicotine has been irritability.
Another method of determining whether tobacco withdrawal symptoms are a result of nicotine deprivation is by examining the signs and symptoms after nicotine gum deprivation.
In a recent study, West and Russell (in press) have shown that symptoms occur after cessation of long-term nicotine gum use. They found that among individuals who have been using 2 mg gum for at least a year, cessation from gum use led to increases in reported irritability, depression, hunger, tiredness and restlessness, and decrease in ability to concentrate and ability to cope.
In addition, they found significant decreases in heart rate.
Interestingly, these symptoms are similar to those we found among smokers undergoing tobacco deprivation (i.e., irritability, hunger, decrease in ability to concentrate, and decreased heart rate).
Inevitably, attempts to clarify the characteristics of tobacco withdrawal generate questions that need to be addressed in further investigations.
More research is necessary to determine which changes observed following tobacco withdrawal are specifically the result of removal of the pharmacological effects of the drug and subsequent return to baseline, the result of interrupting a positively reinforced behavior (Falk 1971) , the occurrence of a disruptive event, or true pharmacological withdrawal symptoms. In addition, further research is required to determine which symptoms of tobacco withdrawal result from deprivation from nicotine. Determination of the symptoms which are a result of behavioral dependence or physical dependence on nicotine can lead to more directed treatment approaches.
For example, craving for tobacco does not seem to be affected by nicotine replacement, therefore behavioral management may be necessary for symptoms of craving rather than pharmacological intervention with nicotine.
